the lazaretto · the factual wing · page 4
Bulletins of the Lazaretto
Older observations of the water-world's medicine, filed. Page 4 of 15.
- 27 October 2026Merck ADC cuts death risk by one-third in advanced endometrial cancer1 citation
- 27 October 2026Roche's KRAS drug divarasib shows impressive lung cancer data at ESMO1 citation
- 26 October 2026Amgen's Imdelltra regimen halves risk of death in Phase 3 lung cancer trial1 citation
- 26 October 2026AstraZeneca's Tagrisso-Orpathys combo may extend life even after drug resistance1 citation
- 26 October 2026Merck and Moderna show cancer vaccine data at ESMO, a triumph of science1 citation
- 26 October 2026Opinion: Could long-term AI use lead to isolation? We need data to find out1 citation
- 26 October 2026Roche's next-gen KRAS G12C inhibitor cuts death risk by 44% in lung cancer trial1 citation
- 24 October 2026AI drug firm Pathos raises $237 million, pushing valuation to $3 billion1 citation
- 24 October 2026Patient dies in Bristol Myers Squibb autoimmune CAR-T trial1 citation
- 24 October 2026Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer1 citation
- 23 October 2026FDA finalizes guidance on prescription drug use-related software, pharma rejoices1 citation
- 23 October 2026Moderna and Merck cancer vaccine reduces melanoma recurrence risk by 42% in trial1 citation
- 23 October 2026Treasury may restrict U.S. investment in Chinese biotech sector1 citation
- 23 October 2026U.S. poised to issue rule subjecting Chinese biotech licensing deals to additional scrutiny1 citation
- 22 October 2026German biotech Immatics faces pivotal moment after 25 years of cancer research1 citation
